Dual targeting of EGFR and focal adhesion kinase in 3D grown HNSCC cell cultures

Radiotherapy and Oncology

Volumn 99, Issue 3, 2011, Pages 279-286

  Eke, Iris ^a   Cordes, Nils ^a,b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

3D cell culture; CETUXIMAB; EGFR; Focal adhesion kinase; Ionizing radiation

Indexed keywords

2 [5 CHLORO 2 (2 METHOXY 4 MORPHOLINOANILINO) 4 PYRIMIDINYLAMINO] N METHYLBENZAMIDE; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; FOCAL ADHESION KINASE; LAMININ; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B;

ARTICLE; CANCER CELL CULTURE; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; FLUORESCENCE MICROSCOPY; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HYPERACTIVITY; IMMUNOFLUORESCENCE; IRRADIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RADIATION EXPOSURE; RADIOSENSITIVITY; RADIOSENSITIZATION; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HEAD AND NECK NEOPLASMS; HUMANS; MORPHOLINES; PHOSPHORYLATION; RADIATION-SENSITIZING AGENTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 79960341728     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.06.006     Document Type: Article

References (50)

1. Overgaard J. Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck - A systematic review and meta-analysis. Radiother Oncol 2011
2. J. Overgaard Chemoradiotherapy of head and neck cancer-can the bumble bee fly? Radiother Oncol 92 2009 1 3
3. J. Mendelsohn, and J. Baselga Epidermal growth factor receptor targeting in cancer Semin Oncol 33 2006 369 385 (Pubitemid 44142736)
4. N.E. Hynes, and G. MacDonald ErbB receptors and signaling pathways in cancer Curr Opin Cell Biol 21 2009 177 184
5. M. Baumann, M. Krause, E. Dikomey, K. Dittmann, W. Dorr, and U. Kasten-Pisula EGFR-targeted anti-cancer drugs in radiotherapy: preclinical evaluation of mechanisms Radiother Oncol 83 2007 238 248 (Pubitemid 46915540)
6. H.P. Rodemann, K. Dittmann, and M. Toulany Radiation-induced EGFR-signaling and control of DNA-damage repair Int J Radiat Biol 83 2007 781 791 (Pubitemid 350219102)
7. M. Toulany, M. Minjgee, R. Kehlbach, J. Chen, M. Baumann, and H.P. Rodemann ErbB2 expression through heterodimerization with erbB1 is necessary for ionizing radiation- but not EGF-induced activation of Akt survival pathway Radiother Oncol 97 2010 338 345
8. F. Di Fiore, R. Sesboue, P. Michel, J.C. Sabourin, and T. Frebourg Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer Br J Cancer 103 2010 1765 1772
9. M. Krause, J. Prager, X. Zhou, A. Yaromina, A. Dorfler, and W. Eicheler EGFR-TK inhibition before radiotherapy reduces tumour volume but does not improve local control: differential response of cancer stem cells and nontumourigenic cells? Radiother Oncol 83 2007 316 325 (Pubitemid 46915543)
10. A. Santiago, W. Eicheler, J. Bussink, P. Rijken, A. Yaromina, and B. Beuthien-Baumann Effect of cetuximab and fractionated irradiation on tumour micro-environment Radiother Oncol 97 2011 322 329
11. N. Zhang, K. Erjala, J. Kulmala, X. Qiu, M. Sundvall, and K. Elenius Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro Radiother Oncol 92 2009 388 392
12. Z. Jing, L. Gong, C.Y. Xie, L. Zhang, H.F. Su, and X. Deng Reverse resistance to radiation in KYSE-150R esophageal carcinoma cell after epidermal growth factor receptor signal pathway inhibition by cetuximab Radiother Oncol 93 2009 468 473
13. J.A. Bonner, P.M. Harari, J. Giralt, R.B. Cohen, C.U. Jones, and R.K. Sur Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival Lancet Oncol 11 2010 21 28
14. J.J. Caudell, S.M. Sawrie, S.A. Spencer, R.A. Desmond, W.R. Carroll, and G.E. Peters Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment Int J Radiat Oncol Biol Phys 71 2008 676 681
15. S. Hehlgans, I. Eke, and N. Cordes An essential role of integrin-linked kinase in the cellular radiosensitivity of normal fibroblasts during the process of cell adhesion and spreading Int J Radiat Biol 83 2007 769 779 (Pubitemid 350219099)
16. M.W. Renshaw, L.S. Price, and M.A. Schwartz Focal adhesion kinase mediates the integrin signaling requirement for growth factor activation of MAP kinase J Cell Biol 147 1999 611 618 (Pubitemid 29523466)
17. A. Tomar, and D.D. Schlaepfer A PAK-activated linker for EGFR and FAK Dev Cell 18 2010 170 172
18. I. Eke, V. Sandfort, A. Mischkus, M. Baumann, and N. Cordes Antiproliferative effects of EGFR tyrosine kinase inhibition and radiation-induced genotoxic injury are attenuated by adhesion to fibronectin Radiother Oncol 80 2006 178 184 (Pubitemid 44301542)
19. I. Eke, V. Sandfort, K. Storch, M. Baumann, B. Roper, and N. Cordes Pharmacological inhibition of EGFR tyrosine kinase affects ILK-mediated cellular radiosensitization in vitro Int J Radiat Biol 83 2007 793 802 (Pubitemid 350219106)
20. N. Cordes, and V. Meineke Cell adhesion-mediated radioresistance (CAM-RR) Extracellular matrix-dependent improvement of cell survival in human tumor and normal cells in vitro Strahlenther Onkol 179 2003 337 344 (Pubitemid 36606025)
21. I. Eke, U. Koch, S. Hehlgans, V. Sandfort, F. Stanchi, and D. Zips PINCH1 regulates Akt1 activation and enhances radioresistance by inhibiting PP1alpha J Clin Invest 120 2010 2516 2527
22. Sandfort V, Eke I, Cordes N. The role of the focal adhesion protein PINCH1 for the radiosensitivity of adhesion and suspension cell cultures. PLoS One 2010;5
23. C. Beinke, D. Van Beuningen, and N. Cordes Ionizing radiation modules of the expression and tyrosine phosphorylation of the focal adhesion-associated proteins focal adhesion kinase (FAK) and its substrates p130cas and paxillin in A549 human lung carcinoma cells in vitro Int J Radiat Biol 79 2003 721 731 (Pubitemid 37378539)
24. T. Kasahara, E. Koguchi, M. Funakoshi, E. Aizu-Yokota, and Y. Sonoda Antiapoptotic action of focal adhesion kinase (FAK) against ionizing radiation Antioxid Redox Signal 4 2002 491 499 (Pubitemid 34753389)
25. N. Cordes, S. Frick, T.B. Brunner, C. Pilarsky, R. Grutzmann, and B. Sipos Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1 Oncogene 26 2007 6851 6862 (Pubitemid 47609078)
26. L.J. Kornberg Focal adhesion kinase and its potential involvement in tumor invasion and metastasis Head Neck 20 1998 745 752 (Pubitemid 28462832)
27. J.H. Park, B.L. Lee, J. Yoon, J. Kim, M.A. Kim, and H.K. Yang Focal adhesion kinase (FAK) gene amplification and its clinical implications in gastric cancer Hum Pathol 41 2010 1664 1673
28. P.M. Siesser, and S.K. Hanks The signaling and biological implications of FAK overexpression in cancer Clin Cancer Res 12 2006 3233 3237
29. J.T. Parsons Focal adhesion kinase: the first ten years J Cell Sci 116 2003 1409 1416 (Pubitemid 36527488)
30. M.C. Frame, H. Patel, B. Serrels, D. Lietha, and M.J. Eck The FERM domain: organizing the structure and function of FAK Nat Rev Mol Cell Biol 11 2010 802 814
31. W. Long, P. Yi, L. Amazit, H.L. LaMarca, F. Ashcroft, and R. Kumar SRC-3Delta4 mediates the interaction of EGFR with FAK to promote cell migration Mol Cell 37 2010 321 332
32. S. Hehlgans, I. Lange, I. Eke, and N. Cordes 3D cell cultures of human head and neck squamous cell carcinoma cells are radiosensitized by the focal adhesion kinase inhibitor TAE226 Radiother Oncol 92 2009 371 378
33. S. Hiscox, P. Barnfather, E. Hayes, P. Bramble, J. Christensen, and R.I. Nicholson Inhibition of focal adhesion kinase suppresses the adverse phenotype of endocrine-resistant breast cancer cells and improves endocrine response in endocrine-sensitive cells Breast Cancer Res Treat 125 2011 659 669
34. V.M. Golubovskaya, C. Virnig, and W.G. Cance TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR Mol Carcinog 47 2008 222 234 (Pubitemid 351398065)
35. E.A. Beierle, X. Ma, J. Stewart, C. Nyberg, A. Trujillo, and W.G. Cance Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma Cell Cycle 9 2010 1005 1015
36. J. Schwock, N. Dhani, M.P. Cao, J. Zheng, R. Clarkson, and N. Radulovich Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts Cancer Res 69 2009 4750 4759
37. N.D. Dhani, H.A. Burris III, L.L. Siu, D.R. Camidge, L.R. Mileshkin, H. Xu, K.J. Pierce, N.R. Fahey, H.J.S. Fingert, and M. Shreeve Final report of phase I clinical, pharmacokinetic (PK), pharmacodynamic (PD) study of PF-00562271 targeting focal adhesion kinase (FAK) in patients (pts) with solid tumors J Clin Oncol 28 2010 15s (suppl; abstr 3028)
38. M.V. Fournier, K.J. Martin, P.A. Kenny, K. Xhaja, I. Bosch, and P. Yaswen Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer Cancer Res 66 2006 7095 7102 (Pubitemid 44197686)
39. C.M. Nelson, and M.J. Bissell Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer Annu Rev Cell Dev Biol 22 2006 287 309
40. I. Eke, F. Leonhardt, K. Storch, S. Hehlgans, and N. Cordes The small molecule inhibitor QLT0267 Radiosensitizes squamous cell carcinoma cells of the head and neck PLoS One 4 2009 e6434
41. K. Storch, I. Eke, K. Borgmann, M. Krause, C. Richter, and K. Becker Three-dimensional cell growth confers radioresistance by chromatin density modification Cancer Res 70 2010 3925 3934
42. F. Pampaloni, E.G. Reynaud, and E.H. Stelzer The third dimension bridges the gap between cell culture and live tissue Nat Rev Mol Cell Biol 8 2007 839 845 (Pubitemid 47462131)
43. Pectasides E, Rampias T, Kountourakis P, Sasaki CT, Kowalski D, Fountzilas G, Zaramboukas T, Rimm DL, Burtness B, Psyrri A. Comparative Prognostic Value of EGFR Protein Expression Compared with FISH for Head and Neck Squamous Cell Carcinoma (HNSCC). Clin Cancer Res 2011;.
44. J.M. Nam, Y. Onodera, M.J. Bissell, and C.C. Park Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin Cancer Res 70 2010 5238 5248
45. V.M. Weaver, S. Lelievre, J.N. Lakins, M.A. Chrenek, J.C. Jones, and F. Giancotti Beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium Cancer Cell 2 2002 205 216 (Pubitemid 41043976)
46. D.J. Sieg, C.R. Hauck, D. Ilic, C.K. Klingbeil, E. Schaefer, and C.H. Damsky FAK integrates growth-factor and integrin signals to promote cell migration Nat Cell Biol 2 2000 249 256
47. E. Cukierman, R. Pankov, D.R. Stevens, and K.M. Yamada Taking cell-matrix adhesions to the third dimension Science 294 2001 1708 1712 (Pubitemid 33104840)
48. K.M. Yamada, and S. Even-Ram Integrin regulation of growth factor receptors Nat Cell Biol 4 2002 E75 E76
49. S. Benavente, S. Huang, E.A. Armstrong, A. Chi, K.T. Hsu, and D.L. Wheeler Establishment and characterization of a model of acquired resistance to epidermal growth factor receptor targeting agents in human cancer cells Clin Cancer Res 15 2009 1585 1592
50. Carrasco-Garcíaa E, Sacedab M, Grassoa S, Rocamora-Revertea L, Condea M, Gómez-Martíneza A, García-Moralesb P, Ferraguta JA, Martínez-Lacacia I. Small tyrosine kinase inhibitors interrupt EGFR signaling by interacting with erbB3 and erbB4 in glioblastoma cell lines Experimental Cell Research 2011;doi: 10.1016/j.yexcr.2011.03.015.